The information contained on this site is intended for institutional investors only, and is published strictly for informational purposes only without regard to the investment objective, financial situation or specific needs of any particular investor. The information is not intended for use by institutional investors in a jurisdiction where distribution or purchase is not authorized.
An institutional investor is one that falls within one or more of the following categories:
If you do not fall within at least one of the above categories you should not access the information contained in the site.
Baron Capital Management, Inc. makes reasonable efforts to ensure the material on the site is as accurate and timely as possible and that disruptions of service are minimal, Baron Capital Management, Inc. makes no warranty or guarantee concerning the availability of this site or the services or the accuracy of the information on it. In addition, the information contained on the site is in no way intended to constitute investment advice, an offer to sell, or a recommendation of any security or investment product. In fact, the products described herein may not be available to, or suitable for, all investors. You should consider, if appropriate, obtaining independent professional advice before making an investment decision. Please consider the charges, risks, expenses and investment objectives carefully before investing. Nothing on this site is intended to constitute legal or tax advice.
Please keep in mind that the opinions and views expressed through the content and commentaries published on the site are just that - opinions and views - and that they are published on the site for informational purposes only. In addition, views and opinions are based on the information available at the time and may not necessarily be shared by Baron Capital Management, Inc., or its employees, in general. As the investing environment changes, so could this information, and Baron Capital Management, Inc. has no responsibility to update it.
Past performance is not a guarantee of future performance. Investment results and principal value will fluctuate so shares, when redeemed, may be worth more or less than their original cost. Investors should be aware of the additional risks associated with investments in non-diversification, undervalued or overlooked companies and investments in specific industries. Additional risks may include those associated with investing in foreign securities, emerging markets, and companies with relatively small market capitalizations.
By selecting “I Agree” below, you confirm that you are an institutional investor or consultant to an institutional investor.
Baron offers accredited non-U.S. investors and qualified tax-exempt U.S. investors a range of options for investing in the equity market. Our investment vehicles include SICAV funds, separate accounts, collective investment trusts, and Baron USA Partners Fund.
This website may not be suitable for everyone, and if you are at all unsure whether an investment product referenced on this website will meet your individual needs, please seek professional advice before proceeding further with such product. Nothing on this website is, or is intended to be, an offer, advice, or an invitation to buy or sell any investments, in any jurisdiction where, or to anyone whom it would be unlawful to do so. By clicking “I Agree” below you acknowledge that you have read and understood this important information. Information on this website is issued by Baron Capital, Inc.
If you are a non-U.S. investor or qualified tax-exempt U.S. investor interested in our non-U.S. investment products, please contact Stephen Millar, VP, Head of EMEA, Institutional Sales | +44(0)7769 958822 | email@example.com
By selecting “I Agree” below, you confirm that you are an accredited non-U.S. investor or a qualified tax-exempt U.S. investor.
The link you have selected is not available within the Institution user experience. You will be switched to view this website as a Financial Advisor.
When you wish to view strategies again, click an 'Institution' link within the 'View As' menu or 'Strategies' in the footer.
Thank you for your email. We will respond as soon as possible.
as of 09/30/22
Although the U.S. equity market stabilized somewhat in the three-month period, 2022 continued to prove to be a challenging year. Sticky inflation data, the expectation of more rate hikes, slowing growth, and the potential for a recession weighed heavily on investor sentiment, and the September quarter ended close to 2022 lows.
U.S. economic signals were mixed. Despite two consecutive quarters of negative GDP growth and near-record lows in consumer confidence, the labor market continued to show unusual strength, and household and company balance sheets overall remained healthy. Inflation stayed stubbornly high, driven by a spike in energy costs, lingering global supply-chain issues, pent-up demand as economies re-opened, and payroll and wage increases as businesses rushed to staff up to meet demand. That said, the Fed’s tighter monetary policy appears to be slowly cooling down some parts of the economy – in particular, the housing market. A concern now is that the Fed will overcorrect and spark a recession. We are starting to see some businesses taking steps in preparation for tougher times ahead, reducing budgets for non-essential functions, shelving technology upgrades, and making other cutbacks.
Baron Focused Growth Fund increased in the quarter. Consumer Discretionary, Communication Services, and Financials investments contributed to performance. Health Care, Information Technology (IT), and Industrials holdings detracted the most. Top contributor Tesla, Inc. led positive returns within Consumer Discretionary. Hyatt Hotels Corp. was another notable contributor within the sector after shares of this global hotelier increased on strong revenue-per-available-room results as business travel continued to recover from pandemic lows. Third largest contributor Iridium Communications Inc. drove gains within Communication Services. Financials benefited from share price increases in financial information and analytics provider FactSet Research Systems, Inc. and investment decision support tools provider MSCI, Inc. Both holdings within Health Care declined, including second largest detractor Figs Inc. Third largest detractor Guidewire Software, Inc. led weakness within IT. Top detractor Space Exploration Technologies Corp. drove declines within the Industrials sector.
As long-term investors who have lived through multiple bear markets, downturns, and even recessions, we have learned not to try to predict the unpredictable. Instead, we focus on identifying and researching well-managed unique businesses with durable competitive advantages and compelling growth prospects and investing in them at attractive prices. We think the combination of unchanged long-term growth outlooks and more compelling valuations should result in attractive returns over time.
as of 09/30/22
as of 09/30/22
When reviewing performance attribution on our portfolio, please be aware that we construct the portfolio from the bottom up, one stock at a time. Each stock is included in the portfolio if it meets our rigorous investment criteria. To help manage risk, we are aware of our sector and security weights, but we do not include a holding to achieve a target sector allocation or to approximate an index. Our exposure to any given sector is purely a result of our stock selection process.
as of 09/30/22
Baron Focused Growth Fund (Institutional Shares) was up 2.18% in the third quarter, outperforming the Russell 2500 Growth Index by 230 basis points due to stock selection and, to a lesser extent, cash exposure in a difficult market environment.
Aside from cash, investments in Consumer Discretionary, Communication Services, and Financials together with limited exposure to the lagging Materials and Real Estate sectors added the most value. Favorable stock selection in Consumer Discretionary was responsible for the bulk of the outperformance in the period, with most of the strength coming from electric vehicle manufacturer Tesla, Inc. Tesla was the top contributor due to increased production volumes from the company’s global factories, new full self-driving functionality, manufacturing techniques that improve quality and reduce costs, and industry-leading margins despite complex COVID-related shutdowns. Global hotelier Hyatt Hotels Corp. also performed well in the sector due to strong revenue-per-available-room results as business travel continued to recover from pandemic lows. While leisure rates dropped a little in the seasonally slower back-to-school period, this decline was expected and was more than offset by increases in business transient and group bookings. Positive stock selection in Communication Services, related to the outperformance of satellite communications company Iridium Communications Inc., was somewhat offset by the Fund’s higher exposure to this poor performing sector. Iridium was the third largest contributor as expectations for smartphone compatibility increased after the company announced a related development agreement and other market participants revealed similar capabilities. Additionally, the company reported record quarterly results, featuring accelerating revenue growth and strong profitability. Performance in Financials was bolstered by financial data providers FactSet Research Systems, Inc. and MSCI, Inc. FactSet continued to fare quite well in the quarter, with the company’s earnings demonstrating strong revenue growth. Similarly, MSCI’s earnings impressed and the underlying business continued to perform well despite broad market weakness, which has hurt the company's asset-based fee revenue.
Investments in Health Care and Industrials detracted the most from relative performance. Within Health Care, lower exposure to strong performing biotechnology stocks coupled with the underperformance of direct-to-consumer health care apparel platform Figs Inc. weighed heavily on performance. Figs was the second largest detractor despite reporting solid quarterly results and reaffirming full-year guidance as the company’s shares participated in the broad market sell-off in late September. Weakness in Industrials came from private rocket and spacecraft manufacturer Space Exploration Technologies Corp., whose shares are valued using prices of recent transactions and a proprietary valuation model.
Investors should consider the investment objectives, risks, and charges and expenses of the investment carefully before investing. The prospectus and summary prospectuses contain this and other information about the Funds. You may obtain them from the Funds’ distributor, Baron Capital, Inc., by calling 1-800-99BARON or visiting www.BaronFunds.com. Please read them carefully before investing.
The performance data quoted represents past performance. Past performance is no guarantee of future results. The investment return and principal value of an investment will fluctuate; an investor's shares, when redeemed, may be worth more or less than their original cost. The Fund’s transfer agency expenses may be reduced by expense offsets from an unaffiliated transfer agent, without which performance would have been lower. Current performance may be lower or higher than the performance data quoted.
Risks:All investments are subject to risk and may lose value.
The discussion of market trends is not intended as advice to any person regarding the advisability of investing in any particular security. The views expressed on this page reflect those of the respective writer. Some of our comments are based on management expectations and are considered “forward-looking statements.” Actual future results, however, may prove to be different from our expectations. Our views are a reflection of our best judgment at the time and are subject to change at any time based on market and other conditions and Baron has no obligation to update them
Portfolio holdings are subject to change. Current and future portfolio holdings are subject to risk.
The index performance is not fund performance; one cannot invest directly into an index.